HAYLEY HILL: Open Payments
NPI 1144063561 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,651 in 61 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $150 · 2025 $1,651
Food & beverage: $1,546Education: $104
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 15 | $322 |
| ABBVIE INC. | 17 | $288 |
| Otsuka America Pharmaceutical, Inc. | 8 | $251 |
| Vanda Pharmaceuticals Inc. | 10 | $224 |
| Axsome Therapeutics, Inc. | 3 | $173 |
| E.R. Squibb & Sons, L.L.C. | 5 | $171 |
| Teva Pharmaceuticals USA, Inc. | 1 | $104 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $99 |
| Lundbeck LLC | 1 | $17 |
Products named: VRAYLAR, REXULTI, FANAPT, COBENFY, ARISTADA, LYBALVI, Auvelity, CAPLYTA.
Industry payments across TX — which companies pay providers there.
